Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Gilbert Donders, Helena Kopp Kallner, Brian Hauck, Anja Bauerfeind, Ann-Kathrin Frenz, Michal Zvolanek & Dale W. Stovall. (2023) Bleeding profile satisfaction and pain and ease of placement with levonorgestrel 19.5 mg IUD: findings from the Kyleena® Satisfaction study. The European Journal of Contraception & Reproductive Health Care 28:1, pages 1-9.
Read now
Read now
Josep Perelló Capó, Gregorio López González, Joan Rius-Tarruella & Joaquim Calaf Alsina. (2022) Real-world satisfaction and menstrual bleeding pattern with available LNG-IUD among Spanish young women. The European Journal of Contraception & Reproductive Health Care 27:6, pages 461-472.
Read now
Read now
Dale W. Stovall, Keith Aqua, Thomas Römer, Gilbert Donders, Terje Sørdal, Brian Hauck, Eric Saucedo de la Llata, Helena Kopp Kallner, Julie Salomon, Michal Zvolanek, Ann-Kathrin Frenz, Tanja Böhnke & Anja Bauerfeind. (2021) Satisfaction and continuation with LNG-IUS 12: findings from the real-world kyleena® satisfaction study. The European Journal of Contraception & Reproductive Health Care 26:6, pages 462-472.
Read now
Read now
Ann-Kathrin Frenz, Christiane Ahlers, Vita Beckert, Christoph Gerlinger & Tim Friede. (2021) Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems. The European Journal of Contraception & Reproductive Health Care 26:1, pages 48-57.
Read now
Read now
Anna M. Teunissen, Audrey H. H. Merry, Ingrid E. C. Devies & Frans J. M. E. Roumen. (2019) Differences in continuation rates and early removal between contraceptive and therapeutic use of the levonorgestrel-releasing intrauterine system 52 mg. The European Journal of Contraception & Reproductive Health Care 24:6, pages 449-456.
Read now
Read now
Norman D. Goldstuck & Hung P. Le. (2018) Delivery of progestins via the subdermal versus the intrauterine route: comparison of the pharmacology and clinical outcomes. Expert Opinion on Drug Delivery 15:7, pages 717-727.
Read now
Read now
Alexandra J. Hawkey, Jane M. Ussher & Janette Perz. (2018) “If You Don’t Have a Baby, You Can’t Be in Our Culture”: Migrant and Refugee Women’s Experiences and Constructions of Fertility and Fertility Control. Women's Reproductive Health 5:2, pages 75-98.
Read now
Read now
Sam Rowlands & Stephen Searle. (2014) Contraceptive implants: current perspectives. Open Access Journal of Contraception 5, pages 73-84.
Read now
Read now
Jennifer Bracken & Cynthia A. Graham. (2014) Young women's attitudes towards, and experiences of, long-acting reversible contraceptives. The European Journal of Contraception & Reproductive Health Care 19:4, pages 276-284.
Read now
Read now
Articles from other publishers (42)
. (2023) FSRH Guideline (March 2023) Intrauterine contraception. BMJ Sexual & Reproductive Health 49:Suppl 1, pages 1-142.
Crossref
Crossref
Lueder M. Fels, Dustin Costescu, Carolina S. Vieira, Jeffrey F. Peipert, Eeva Lukkari-Lax, Birte M. Hofmann, Isabel Reinecke, Stefan Klein, Katrin Wiesinger, Bernhard Lindenthal & Runa Speer. (2023) The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial. American Journal of Obstetrics and Gynecology 228:3, pages 322.e1-322.e15.
Crossref
Crossref
A. Martínez Pérez, J. Terrón Barroso, N. Alayón Hernández & N.E. Ariza Chana. (2023) Métodos anticonceptivos de larga duración (LARC): características de las usuarias, tasa de continuidad y efectividad. Clínica e Investigación en Ginecología y Obstetricia 50:1, pages 100800.
Crossref
Crossref
Birte Maria Hofmann, Manja Ahola, Lueder M. Fels, Stefan Klein, Bernhard Lindenthal & Jyrki Pihlaja. (2023) Development of an Intrauterine Device Releasing Both Indomethacin and Levonorgestrel During the First Months of Use: Pharmacokinetic Characterization in Healthy Women. Clinical Pharmacokinetics 62:1, pages 113-126.
Crossref
Crossref
Cassandra Caddy, Henrietta Williams, Jane Hocking & Jacqueline Coombe. (2022) “I never went to see that doctor again”: A qualitative study examining Australian women's experiences requesting removal of LARC within 12 months of insertion. Contraception 110, pages 81-85.
Crossref
Crossref
Deepak Ramazor Gupta, Bala Prabhakar & Sarika Wairkar. (2022) Non-oral routes, novel formulations and devices of contraceptives: An update. Journal of Controlled Release 345, pages 798-810.
Crossref
Crossref
Dustin Costescu, Rajinder Chawla, Rowena Hughes, Stephanie Teal & Martin Merz. (2022) Discontinuation rates of intrauterine contraception due to unfavourable bleeding: a systematic review. BMC Women's Health 22:1.
Crossref
Crossref
Koyel Halder, RathindraNath Ray, Priyam Biswas, Pritha Kolay, Shefali Kumari & Dibyojyoti Das. (2022) Evaluation of the efficacy of levonorgestrel intrauterine system in the management of heavy menstrual bleeding: An analytical observational study. MGM Journal of Medical Sciences 9:1, pages 42.
Crossref
Crossref
Hana Tesfaye, Ebissa Negara & Kenbon Bayisa. (2021) Early implanon discontinuation and associated factors among women ever used implanon in Mettu district, Oromia regional state, southwest Ethiopia, 2021. Reproductive Health 18:1.
Crossref
Crossref
Kusum V. Moray, Himanshu Chaurasia, Oshima Sachin & Beena Joshi. (2021) A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant. Reproductive Health 18:1.
Crossref
Crossref
Sarah Green, Jeanelle Sheeder & Molly Richards. (2021) The Etonogestrel Implant in Adolescents: Factors Associated With Removal for Bothersome Bleeding in the First Year After Insertion. Journal of Pediatric and Adolescent Gynecology 34:6, pages 825-831.
Crossref
Crossref
Toeresin Karakoyun, Hans-Peter Podhaisky, Ann-Kathrin Frenz, Gabriele Schuhmann-Giampieri, Thais Ushikusa, Daniel Schröder, Michal Zvolanek & Agnaldo Lopes Da Silva Filho. (2021) Digital Medical Device Companion (MyIUS) for New Users of Intrauterine Systems: App Development Study. JMIR Medical Informatics 9:7, pages e24633.
Crossref
Crossref
Eka Rusdianto Gunardi & Sulaeman Andrianto Susilo. (2021) Menstrual Pattern and Characteristics of One-Rod and Two-Rod Levonorgestrel Implant Users. Obstetrics and Gynecology International 2021, pages 1-7.
Crossref
Crossref
. (2021) FSRH Guideline (February 2021) Progestogen-only Implant. BMJ Sexual & Reproductive Health 47:Suppl 1, pages 1-62.
Crossref
Crossref
Julie H. Hernandez, Pierre Akilimali, Annie Glover & Jane T. Bertrand. (2020) Feasibility and acceptability of using medical and nursing students to provide Implanon NXT at the community level in Kinshasa, Democratic Republic of Congo. BMC Women's Health 20:1.
Crossref
Crossref
Tuire H. Saloranta, Frida K. Gyllenberg, Anna But, Mika Gissler, Merja K. Laine & Oskari Heikinheimo. (2020) Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons. American Journal of Obstetrics and Gynecology 223:6, pages 886.e1-886.e17.
Crossref
Crossref
Elise D. Berlan, Molly J. Richards, Carolina Sales Vieira, Mitchell D. Creinin, Andrew M. Kaunitz, Ian S. Fraser, Alison Edelman & Diana Mansour. (2020) Best Practices for Counseling Adolescents about the Etonogestrel Implant. Journal of Pediatric and Adolescent Gynecology 33:5, pages 448-454.
Crossref
Crossref
Lauren Y. Maldonado, Jill E. Sergison, Xiaoming Gao & David Hubacher. (2020) Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52 mg) during the first-year after insertion: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 222:5, pages 451-468.e9.
Crossref
Crossref
Kristine Concepcion, Sarina Lacey, Kevin McGeechan, Jane Estoesta, Deborah Bateson & Jessica Botfield. (2020) Cost–benefit analysis of enhancing the uptake of long-acting reversible contraception in Australia. Australian Health Review 44:3, pages 385.
Crossref
Crossref
Krishna Gautam, Shreya Dwivedi, Dhirendra Singh & Sadasivam Anbumani. 2020. Toxicological Aspects of Medical Device Implants. Toxicological Aspects of Medical Device Implants
135
157
.
Jill E. Sergison, Lauren Y. Maldonado, Xiaoming Gao & David Hubacher. (2019) Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis. American Journal of Obstetrics and Gynecology 220:5, pages 440-448.e8.
Crossref
Crossref
Jacqueline Coombe, Melissa L. Harris & Deborah Loxton. (2019) Motivators of contraceptive method change and implications for long-acting reversible contraception (non-)use: A qualitative free-text analysis. Sexual & Reproductive Healthcare 19, pages 71-77.
Crossref
Crossref
Chelsea B. Polis, Rubina Hussain & Amanda Berry. (2018) There might be blood: a scoping review on women’s responses to contraceptive-induced menstrual bleeding changes. Reproductive Health 15:1.
Crossref
Crossref
Amie L. Bingham, Cameryn C. Garrett, Christine Bayly, Anne M. Kavanagh, Louise A. Keogh, Rebecca J. Bentley & Jane S. Hocking. (2018) The levonorgestrel intrauterine device in Australia: analysis of prescribing data 2008–2012. BMC Women's Health 18:1.
Crossref
Crossref
Jessica N. Sanders, Jenny A. Higgins, Daniel E. Adkins, Greggory J. Stoddard, Lori M. Gawron & David K. Turok. (2018) The Impact of Sexual Satisfaction, Functioning, and Perceived Contraceptive Effects on Sex Life on IUD and Implant Continuation at 1 Year. Women's Health Issues 28:5, pages 401-407.
Crossref
Crossref
Brett L. Worly, Tamar L. Gur & Jonathan Schaffir. (2018) The relationship between progestin hormonal contraception and depression: a systematic review. Contraception 97:6, pages 478-489.
Crossref
Crossref
Denisa L. Goldhammer, Catriona Fraser, Britta Wigginton, Melissa L. Harris, Deborah Bateson, Deborah Loxton, Mary Stewart, Jacqueline Coombe & Jayne C. Lucke. (2017) What do young Australian women want (when talking to doctors about contraception)?. BMC Family Practice 18:1.
Crossref
Crossref
Louise F. Wilson, Nirmala Pandeya & Gita D. Mishra. (2017) Hysterectomy trends in Australia, 2000–2001 to 2013–2014: joinpoint regression analysis. Acta Obstetricia et Gynecologica Scandinavica 96:10, pages 1170-1179.
Crossref
Crossref
Kumiyo Inoue, Marguerite Kelly, Alexandra Barratt, Deborah Bateson, Alison Rutherford, Kirsten I Black, Mary Stewart & Juliet Richters. (2017) Australian women's attitudes towards and understandings of the subdermal contraceptive implant: a qualitative study of never-users. Journal of Family Planning and Reproductive Health Care 43:2, pages 128-134.
Crossref
Crossref
Jacqueline Coombe, Melissa L. Harris & Deborah Loxton. (2017) Who uses long-acting reversible contraception? Profile of LARC users in the CUPID cohort. Sexual & Reproductive Healthcare 11, pages 19-24.
Crossref
Crossref
Deborah Bateson, Caroline Harvey, Lieu Trinh, Mary Stewart & Kirsten I. Black. (2016) User characteristics, experiences and continuation rates of copper intrauterine device use in a cohort of Australian women. Australian and New Zealand Journal of Obstetrics and Gynaecology 56:6, pages 655-661.
Crossref
Crossref
Moazzam Ali, Ayse Akin, Luis Bahamondes, Vivian Brache, Ndema Habib, Sihem Landoulsi & David Hubacher. (2016) Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant. Human Reproduction 31:11, pages 2491-2498.
Crossref
Crossref
Khadra A. Jama-Alol, Alexandra P. Bremner, Louise M. Stewart, Anna Kemp-Casey, Eva Malacova, Rachael Moorin, Adeleh Shirangi & David B. Preen. (2016) Declining rates of sterilization procedures in Western Australian women from 1990 to 2008: the relationship with age, hospital type, and government policy changes. Fertility and Sterility 106:3, pages 704-709.e1.
Crossref
Crossref
Daniel P. Chiles, Timothy A. Roberts & David A. Klein. (2016) Initiation and continuation of long-acting reversible contraception in the United States military healthcare system. American Journal of Obstetrics and Gynecology 215:3, pages 328.e1-328.e9.
Crossref
Crossref
Frederick Schatz, Ozlem Guzeloglu-Kayisli, Sefa Arlier, Umit A. Kayisli & Charles J. Lockwood. (2016) The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding. Human Reproduction Update 22:4, pages 497-515.
Crossref
Crossref
Varsha Jain & Virginia E Wotring. (2016) Medically induced amenorrhea in female astronauts. npj Microgravity 2:1.
Crossref
Crossref
Kirsten I. BlackCarolyn A. Day. (2016) Improving Access to Long-Acting Contraceptive Methods and Reducing Unplanned Pregnancy among Women with Substance Use Disorders. Substance Abuse: Research and Treatment 10s1, pages SART.S34555.
Crossref
Crossref
D. Hubacher. (2015) The Levonorgestrel Intrauterine System: Reasons to Expand Access to the Public Sector of Africa. Global Health: Science and Practice 3:4, pages 532-537.
Crossref
Crossref
Justin T. Diedrich, Qiuhong Zhao, Tessa Madden, Gina M. Secura & Jeffrey F. Peipert. (2015) Three-year continuation of reversible contraception. American Journal of Obstetrics and Gynecology 213:5, pages 662.e1-662.e8.
Crossref
Crossref
Ozlem Guzeloglu Kayisli, Umit A. Kayisli, Murat Basar, Nihan Semerci, Frederick Schatz & Charles J. Lockwood. (2015) Progestins Upregulate FKBP51 Expression in Human Endometrial Stromal Cells to Induce Functional Progesterone and Glucocorticoid Withdrawal: Implications for Contraceptive- Associated Abnormal Uterine Bleeding. PLOS ONE 10:10, pages e0137855.
Crossref
Crossref
Maryam Guiahi, Madeline McBride, Jeanelle Sheeder & Stephanie Teal. (2015) Short-Term Treatment of Bothersome Bleeding for Etonogestrel Implant Users Using a 14-Day Oral Contraceptive Pill Regimen. Obstetrics & Gynecology 126:3, pages 508-513.
Crossref
Crossref
Jennifer Amico, Bhavik Kumar, Hilary Rosenstein & Marji Gold. (2015) The Contraceptive Implant: An Updated Review of the Evidence. Current Obstetrics and Gynecology Reports 4:1, pages 79-88.
Crossref
Crossref